Shock wave lithotripsy in patients requiring anticoagulation or antiplatelet agents

Auteurs-es

  • Bader Alsaikhan Department of Urology, McGill University Health Centre, Montreal, QC
  • Sero Andonian Department of Urology, McGill University Health Centre, Montreal, QC

DOI :

https://doi.org/10.5489/cuaj.566

Résumé

Extracorporeal shockwave lithotripsy (SWL) remains the only truly
minimally invasive procedure for the treatment of upper tract nephrolithiasis.
Recently, there has been a recent rise in the patients
on antiplatelet agents. Therefore, the aim of the present study is
to review the literature available regarding SWL in these high-risk
patients requiring anti-coagulation therapy. Alternative therapies
to SWL are also presented.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Bibliographies de l'auteur-e

Bader Alsaikhan, Department of Urology, McGill University Health Centre, Montreal, QC

Sero Andonian, Department of Urology, McGill University Health Centre, Montreal, QC

Téléchargements

Comment citer

Alsaikhan, B., & Andonian, S. (2013). Shock wave lithotripsy in patients requiring anticoagulation or antiplatelet agents. Canadian Urological Association Journal, 5(1), 53–7. https://doi.org/10.5489/cuaj.566

Numéro

Rubrique

Review